Skip to content

Obese Pregnant Women: Optimizing Fetal Ultrasound

Obese Pregnant Women: Optimizing Mid-trimester Fetal Ultrasound for Risk Estimation During Pregnancy and Childhood

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02487641
Enrollment
180
Registered
2015-07-01
Start date
2015-06-30
Completion date
2017-03-31
Last updated
2015-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Malformation, Obesity

Keywords

Ultrasound, mid-trimester, Obesity, pregnancy

Brief summary

This study aim to evaluate the quality of fetal ultrasound in obese pregnant women. The hypotheses is that an early ultrasound will improve the quality of the ultrasound in obese.

Detailed description

Ultrasound examination for fetal anomaly is especially challenging in obese gravida. The foetus is more likely to have congenital anomalies and imaging in these patients is technically more difficult. The investigators hypotheses that an earlier ultrasound with alternative technics will improve the quality and thereby improve the identification of anomalies. By using transvaginal ultrasound and abdominal ultrasound at the window just above the symphysis, were the subcutaneous fat is known to be thinner, the investigators hope to achieve a better overview. This will be done by evaluating fetal ultrasound at three different gestational ages (GA); GA 13, 15 and 21 weeks.

Interventions

None listed

Sponsors

Odense University Hospital
CollaboratorOTHER
Technical University of Denmark
CollaboratorOTHER
Holbaek Sygehus
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 * BMI ≥ 30 Kg/m2 * BMI: 18,5-25 Kg/m2 * Understand and speak Danish and thereby be able to give confirmed consent.

Exclusion criteria

* Multiple gestations * Overweight (BMI: 25-29,9 Kg/m2) * Alcohol or drug abuse * Chronically diseases before pregnancy as diabetes, hypertension, or thyroid diseases * Gastric bypass or other obesity related surgery

Design outcomes

Primary

MeasureTime frameDescription
Image quality of ultrasound at 15 compared with 21 weeks of gestation.The participants will be examined for an hour at to different stages of the pregnancy (GA 14+0-15+0, GA 20+0-21+0)Image quality evaluated by experts on a visual analog scale from +50 - -50, parried with standardized ultrasound pictures at the above mentioned GA.

Secondary

MeasureTime frameDescription
Image quality of ultrasound at 13 compared with 15 weeks of gestation.The participants will be examined for an hour at to different stages of the pregnancy (GA 11+3 - 13+0, GA 14+0-15+0)Image quality evaluated by experts on a visual analog scale from +50 - -50, parried with standardized ultrasound pictures at the above mentioned GA.
Analyses of BMI, visceral to subcutaneous fat ratio, distance from cutis to amnion and hip-waist ratio´s influence on image quality.The participants will be examined for an hour at three different stages of the pregnancy (GA 13, GA 15, GA 21 and GA 36 weeks).
Weight estimateThe participants will be examined for an hour at GA 36 weeks. The participants will in all be followed until 6 months after birth, which is one year in all.The use of weight estimate in obese pregnant women at GA 36 compared to birthweight.
Amnion fluid in obeseThe participants will be examined for an hour at three different stages of the pregnancy (GA 15, GA 21, GA 36 weeks)Measurement of amnion fluid by deepest vertical pocket and amnion fluid index.
Crown-rump length (CRL) measurement transvaginal and abdominalThe participants will be examined for an hour at GA 13 weeks.Measurement of CRL in mm, by using two different probes, transvaginal and abdominal.

Countries

Denmark

Contacts

Primary ContactIda Näslund Thagaard, M.D.
idanaeslund@gmail.com/ains@regionsjaelland.dk004522890524
Backup ContactLone Krebs, M.D; DSMc
lkrb@regionsjaelland.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026